Edesa Biotech, Inc. (EDSA)
3.67
+1.39
(+60.96%)
USD |
NASDAQ |
Mar 03, 12:49
Edesa Biotech Cash from Investing (Quarterly) : 0.00 for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -0.0051M |
| Aurinia Pharmaceuticals, Inc. | -36.89M |
| Lexaria Bioscience Corp. | -0.0051M |
| Xenon Pharmaceuticals, Inc. | 60.79M |
| ProMIS Neurosciences, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.087M |
| Cash from Financing (Quarterly) | 3.355M |
| Free Cash Flow | -8.004M |
| Free Cash Flow Per Share (Quarterly) | -0.2618 |
| Free Cash Flow to Equity (Quarterly) | -2.087M |
| Free Cash Flow to Firm (Quarterly) | -2.087M |
| Free Cash Flow Yield | -31.88% |